Internal Medicine, Medical Oncology · Norton Shores, MI
NPI
1215936158
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6425 S. Harvey St
Norton Shores, MI, 49444
Phone (231) 737-3469
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
101,882 services
Medicare patients, 2024
321
Average age 73
Drug cost, 2024
$4.4M
2,686 prescriptions
Company payments, 2025
$3,760
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly J Parling-Lynch was code J1437 (injection, ferric derisomaltose, 10 mg), 1,500 times for 13 patients. In total Kelly J Parling-Lynch billed 101,882 services in 188 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-13.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,500 | 13 | $16.10 | $24K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,222 | 37 | $0.09 | $108 |
| 36415 Venipuncture Blood Collection | Office | 923 | 162 | $8.63 | $7,968 |
| 85025 Blood Count | Office | 882 | 161 | $7.59 | $6,693 |
| 80053 Clinical Chemistry | Office | 563 | 121 | $10.30 | $5,800 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 474 | 13 | $0.24 | $112 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 350 | 14 | $0.64 | $224 |
| 96413 Chemotherapy Administration | Office | 268 | 57 | $90.20 | $24K |
| 96375 Injection Administration | Office | 265 | 53 | $10.65 | $2,823 |
| J9045 Injection, carboplatin, 50 mg | Office | 253 | 12 | $2.78 | $704 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 174 | 18 | $4.62 | $805 |
| 99214 Office E&M - Established | Office | 158 | 90 | $92.03 | $15K |
| 83735 Clinical Chemistry | Office | 154 | 36 | $6.57 | $1,012 |
| 84443 Clinical Chemistry | Office | 149 | 52 | $16.46 | $2,453 |
| 82728 Clinical Chemistry | Office | 131 | 67 | $13.36 | $1,750 |
By year: 2022 $1.7M for 98,809 services; 2023 $1.8M for 131,154 services; 2024 $1.8M for 101,882 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 923 | 162 | $8.63 | $7,968 |
| 85025 Blood Count | 882 | 161 | $7.59 | $6,693 |
| 80053 Clinical Chemistry | 563 | 121 | $10.30 | $5,800 |
| 83735 Clinical Chemistry | 154 | 36 | $6.57 | $1,012 |
| 84443 Clinical Chemistry | 149 | 52 | $16.46 | $2,453 |
| 82728 Clinical Chemistry | 131 | 67 | $13.36 | $1,750 |
| 84466 Clinical Chemistry | 84 | 47 | $12.50 | $1,050 |
| 83540 Clinical Chemistry | 83 | 47 | $6.34 | $526 |
| 82784 Immunoassay | 78 | 11 | $9.11 | $711 |
| 86304 Immunoassay | 57 | 17 | $20.39 | $1,162 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelly J Parling-Lynch prescribed most often to Medicare patients was Letrozole, with 168 prescriptions and refills. In total Kelly J Parling-Lynch wrote 2,686 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 168 | 434 | 54 | $5,563 |
| Acyclovir Generic | 161 | 201 | 40 | $2,029 |
| Prochlorperazine Maleate Generic | 157 | 157 | 102 | $2,286 |
| Prednisone Generic | 146 | 155 | 58 | $490 |
| Levothyroxine Sodium Generic | 133 | 191 | 30 | $1,257 |
| Olanzapine Generic | 126 | 126 | 45 | $286 |
| Dexamethasone Generic | 103 | 116 | 48 | $1,272 |
| Hydroxyurea Generic | 86 | 187 | 23 | $2,440 |
| Eliquis Apixaban | 82 | 105 | 22 | $56K |
| Anastrozole Generic | 67 | 191 | 23 | $2,034 |
| Xarelto Rivaroxaban | 65 | 98 | Under 11 | $50K |
| Tamoxifen Citrate Generic | 52 | 134 | 17 | $1,862 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 51 | 57 | 47 | $544 |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $756K |
| Allopurinol Generic | 45 | 67 | Under 11 | $473 |
Brand drugs: 522 claims; generic drugs: 2,164 claims; opioid claims: 121.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly J Parling-Lynch $3,760 ($3,760 in general payments such as food, travel and fees) from 50 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $520.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $520 |
| Genentech USA, Inc. ROG.SW | 12 | $227 |
| GlaxoSmithKline, LLC. GSK | 10 | $215 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $210 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $193 |
| Pfizer Inc. PFE | 9 | $159 |
| Merck Sharp & Dohme LLC MRK | 6 | $159 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $130 |
| Aveo Pharmaceuticals, Inc. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.